Lapatinib - Overview and Current Role in Metastatic Breast Cancer
Author:
Affiliation:
1. Consultant Medical Oncologist, Mount Medical Centre, Australia.
Publisher
Korean Cancer Association
Subject
Cancer Research,Oncology
Link
http://www.e-crt.org/upload/pdf/crt-38-198.pdf
Reference8 articles.
1. Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene
2. Activity of the Dual Kinase Inhibitor Lapatinib (GW572016) against HER-2-Overexpressing and Trastuzumab-Treated Breast Cancer Cells
3. Phase I Safety, Pharmacokinetics, and Clinical Activity Study of Lapatinib (GW572016), a Reversible Dual Inhibitor of Epidermal Growth Factor Receptor Tyrosine Kinases, in Heavily Pretreated Patients With Metastatic Carcinomas
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The landscape of exosomal non-coding RNAs in breast cancer drug resistance, focusing on underlying molecular mechanisms;Frontiers in Pharmacology;2023-04-19
2. Circular RNA circ-MMP11 Contributes to Lapatinib Resistance of Breast Cancer Cells by Regulating the miR-153-3p/ANLN Axis;Frontiers in Oncology;2021-07-06
3. Activated estrogen receptor‐mitogen‐activated protein kinases cross talk confer acquired resistance to lapatinib;Thoracic Cancer;2015-02-13
4. Clinical features and outcome of leptomeningeal metastasis in patients with breast cancer: a single center experience;Cancer Chemotherapy and Pharmacology;2013-05-14
5. Lapatinib – kezelési lehetőség trastuzumab-rezisztens emlőrákban;Magyar Onkológia;2009-12-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3